Results 141 to 150 of about 22,217 (292)

NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian Efficacy

open access: yesMovement Disorders, EarlyView.
Abstract Background Levodopa‐induced dyskinesia (LID) in Parkinson's disease (PD) is associated with ‘false neurotransmitter’ release of dopamine from serotonin (5‐HT) neurons. NLX‐112 is a first‐in‐class, highly selective 5‐HT1A receptor agonist which counteracts LIDs in experimental PD models.
Per Svenningsson   +13 more
wiley   +1 more source

G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT This review provides a comprehensive overview of the role of G9a/EHMT2, focusing on its structure and exploring the impact of its pharmacological and/or gene inhibition in various neurological diseases. In addition, we delve into the advancements in the design and synthesis of G9a/EHMT2 inhibitors, which hold promise not only as a treatment ...
Aina Bellver‐Sanchis   +10 more
wiley   +1 more source

Developmental transcriptomes predict adult social behaviours in the socially flexible sweat bee, Lasioglossum baleicum

open access: yesMolecular Ecology, EarlyView., 2023
Abstract Natural variation can provide important insights into the genetic and environmental factors that shape social behaviour and its evolution. The sweat bee, Lasioglossum baleicum, is a socially flexible bee capable of producing both solitary and eusocial nests.
Kennedy S. Omufwoko   +5 more
wiley   +1 more source

Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus [PDF]

open access: hybrid, 1991
D. A. Hosford   +7 more
openalex   +1 more source

An overview of the non‐procedural treatment options for peripheral neuropathic pain

open access: yesMuscle &Nerve, EarlyView.
Abstract Peripheral neuropathic pain is common in patients with peripheral nerve injury and can significantly impact both their function and quality of life. There is a wide variety of non‐interventional treatment approaches, including pharmacologic therapy, physical/occupational therapy, modalities (therapeutic, mechanical, thermal, etc.), psychology,
Evan R. Zeldin   +6 more
wiley   +1 more source

Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives Acute cerebral ischemia is characterized by several pathological processes evolving during time, which contribute to the final tissue damage. Secondary processes, such as prolonged inflammatory response, impaired mitochondrial function and oxidative stress, are responsible for the progression of brain injury to the peri‐infarct area,
Fioravante Capone   +8 more
wiley   +1 more source

Oral microbiota and central nervous system diseases: A review

open access: yesNeuroprotection, EarlyView.
Potential mechanisms between the oral microbiome and brain. Created with BioGDP.com85. a. Oral microbiota and pathogens invasion through the oral mucosal barrier; b. Immune‐inflammation response within the host caused by bacterial invasion; c. Cytokines traversed through the brain‐blood barrier activate neuroinflammation; d.
Xiaoxuan Zhang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy